A microalbumin urine test is the screening test used to catch kidney damage at the stage where nothing hurts, nothing looks different and standard kidney blood tests are still normal. The prefix does not refer to a special kind of albumin. It refers to a small quantity of ordinary albumin, too little for a routine dipstick to register but enough to signal that the kidney’s filters have started to leak.
In this article you will learn why the test is named as it is, who should have it and how often, what the result categories mean, why one abnormal value never settles the question, what happens after a confirmed result, and what recent research shows about treatment.
What the test screens for
Each kidney holds roughly a million microscopic filters. In health they keep almost all albumin, the most abundant blood protein, inside the bloodstream. Damage to those filters, most often from years of raised blood sugar or blood pressure, makes them slightly leaky. Small amounts of albumin start crossing into urine.
The quantity involved at this early stage is far below what a standard dipstick can detect, which is why a specific and sensitive measurement is required. That is the entire purpose of the microalbumin test: to find the leak while it is still small, because that is when treatment does the most good.
The result is almost always reported against creatinine, the muscle waste product used to correct for how concentrated the sample was. Our urine creatinine test guide explains that correction, and the arithmetic behind the ratio is covered in our albumin to creatinine ratio guide.
A note on the terminology
Older reports use microalbuminuria for values between 30 and 300 mg per gram of creatinine and macroalbuminuria for values above that. Current kidney guidelines prefer moderately increased and severely increased albuminuria, on the grounds that the older labels implied a sharp boundary where the evidence shows a continuous gradient of risk. Both vocabularies describe the same thresholds, and you may encounter either.
Who should be tested and how often
- Anyone with diabetes, typically once or twice a year, since diabetic kidney disease is the leading cause of kidney failure. Our guide to diabetes symptoms and treatments sets out the wider care picture.
- People with high blood pressure, described in our guide to high blood pressure symptoms and treatments.
- People with heart disease or heart failure.
- People with a family history of kidney failure.
- Anyone with an already reduced filtration rate, discussed in our eGFR blood test guide.
- People taking medication known to affect the kidneys over the long term.
Screening is worthwhile precisely because early kidney damage is silent. Waiting for symptoms means waiting until a large share of function has already been lost.
How to read your result
| Result | Older term | What happens next |
|---|---|---|
| Under 30 mg/g | Normal | Continue routine screening at the agreed interval |
| 30 to 299 mg/g | Microalbuminuria | Repeat testing to confirm, then review blood pressure, blood sugar and medication |
| 300 mg/g or more | Macroalbuminuria | Prompt evaluation, treatment intensification and often specialist referral |
Confirmation is standard. The usual approach is to repeat the test over the following three to six months; if two of three samples are abnormal, the leakage is considered persistent. Acting on one value risks starting treatment for what was in fact a temporary rise.
Why a single result can mislead
Albumin excretion varies considerably from day to day, and several ordinary situations push it up temporarily:
| Situation | Effect on the result |
|---|---|
| Vigorous exercise within 24 hours | Temporarily higher |
| Fever or acute illness | Temporarily higher |
| Dehydration or extreme cold | Temporarily higher |
| Urinary tract infection | Higher and unreliable; postpone the test |
| Menstrual bleeding or blood in the sample | Higher and unreliable |
| A large meat meal beforehand | Raises creatinine, lowering the calculated ratio |
| Very high or very low muscle mass | Shifts the ratio in the opposite direction to creatinine |
Simple preparation removes most of these: avoid intense exercise and a heavy meat meal for 24 hours, postpone the test during an infection or period, and give a first morning sample where possible. Our urine culture results guide explains how infection is confirmed if that is a question.
What happens after a confirmed abnormal result
A confirmed raised value is not a diagnosis of kidney failure. It is an early warning that usually leads to a set of concrete steps:
- Reviewing blood pressure control, often with a target lower than the general population target.
- Reviewing blood sugar control if you have diabetes, using the markers described in our fasting glucose test guide.
- Starting or adjusting a medication with kidney-protective effects.
- Checking filtration rate and repeating it to see whether it is stable.
- Reviewing medications that may be adding to kidney strain.
- Discussing salt intake, weight, smoking and physical activity.
- Setting a monitoring interval, since the trend over time matters more than any single value.
Our guide to chronic kidney disease symptoms and treatments describes what long-term management involves if leakage persists.
When to talk with a clinician
- Any first result of 30 mg/g or above, so that confirmation can be organized.
- A result of 300 mg/g or above, which merits prompt assessment.
- Values that keep climbing across repeated tests.
- New swelling of the ankles, hands or face, or persistently foamy urine.
- A falling filtration rate alongside a raised albumin value.
- Blood pressure above target despite treatment.
Latest scientific advances
Research over the last three years has strengthened the case for screening and shown how much the number can be moved.
A 2023 individual-participant meta-analysis in JAMA, pooling 114 global cohorts, showed that higher albumin leakage and lower filtration were each independently linked to ten adverse outcomes including kidney failure, death, heart attack, stroke and hospital admission, and that risk began rising within the mildest categories. What this means for you: the 30 mg/g threshold is not the point at which risk begins, it is the point at which it becomes reliably detectable, which is why a modest elevation is taken seriously.
A 2023 analysis in Circulation estimated the combined effect of three modern drug classes in people with type 2 diabetes and a ratio of 30 mg/g or above. Compared with conventional care, combination treatment was projected to add roughly three years free of major cardiovascular events and around five years free of kidney disease progression for someone starting at age 50. What this means for you: a screening test that finds early leakage identifies exactly the people who gain most from these treatments. The figures come from modeling built on trial data rather than from a single trial of the full combination.
A 2025 state-of-the-art review in Circulation described albumin leakage as a unifying marker across heart, kidney and metabolic conditions, while noting that how broadly and how often to screen remains an open question, as does whether to treat low-grade values between 10 and 30 mg/g. What this means for you: the screening intervals you are offered reflect current consensus and may be refined in the coming years.
Glossary
| Term | Definition |
|---|---|
| Microalbumin | A small quantity of ordinary albumin in urine, too little for a routine dipstick to detect. |
| Microalbuminuria | The older name for a ratio between 30 and 300 mg per gram of creatinine. |
| Macroalbuminuria | The older name for a ratio of 300 mg per gram of creatinine or above. |
| Moderately increased albuminuria | The current term for the 30 to 300 mg/g category. |
| Diabetic kidney disease | Kidney damage caused by diabetes, historically called diabetic nephropathy. |
| Glomerulus | One of the microscopic filtering units of the kidney, around a million per kidney. |
| Creatinine | A muscle waste product used to correct urine results for how concentrated the sample was. |
| eGFR | Estimated glomerular filtration rate, a blood-based measure of filtering capacity. |
| Screening | Testing people without symptoms in order to find a condition early enough to change its course. |
Frequently asked questions
Is microalbumin a different protein from albumin?
No. It is the same protein, and the prefix refers only to the small quantity being measured. The name has persisted from an era before current terminology, which is why many reports now say moderately increased albuminuria instead. If your report uses either wording, the thresholds are the same.
Does an abnormal result mean I have kidney disease?
Not on the strength of one sample. A temporary rise from exercise, fever or infection is common, which is why the result is confirmed over three to six months. If leakage is persistent, it does indicate early kidney damage, and that is precisely the stage at which treatment can slow or halt progression.
Can the result improve?
Often, yes. Better blood pressure and blood sugar control, together with kidney-protective medication, frequently lowers the value, and a falling value generally accompanies slower loss of kidney function. Some people return to the normal category. How much improvement is possible depends on the cause and on how early it was detected.
Do I need to fast or collect urine for 24 hours?
Neither, in most cases. A single random sample corrected for creatinine is the standard method and performs well for screening. A first morning sample is often preferred. Avoid intense exercise and a heavy meat meal for 24 hours beforehand, and postpone the test if you have a urinary infection.
Why is this test done if my kidney blood test is normal?
Because albumin leakage usually appears years before filtration measurably declines. A normal creatinine or filtration estimate does not rule out early damage. Screening both is standard practice, and the two results together give a far better picture of risk than either does alone.
How often should I be screened if I have diabetes?
Commonly once or twice a year, though your clinician may test more often if a previous result was abnormal or if your blood pressure or blood sugar control has changed. The interval is a clinical judgment based on your own risk, so it is worth asking explicitly what schedule applies to you.
Sources
- MedlinePlus, National Library of Medicine — Microalbumin Creatinine Ratio — MedlinePlus Medical Test, reviewed 2025 — medlineplus.gov
- Mayo Clinic — Protein in urine (microalbumin test) — Mayo Clinic Tests and Procedures, 2025 — mayoclinic.org
- National Institute of Diabetes and Digestive and Kidney Diseases — Quick Reference on UACR and GFR — NIDDK Health Information, 2025 — niddk.nih.gov
- Grams ME, Coresh J, Matsushita K, Ballew SH, Sang Y, Surapaneni A, Levey AS, Gansevoort RT — Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis — JAMA, 2023 — doi.org/10.1001/jama.2023.17002
- Neuen BL, Heerspink HJL, Vart P, Claggett BL, Fletcher RA, Arnott C, Perkovic V, Solomon SD, Vaduganathan M — Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA — Circulation, 2023 — doi.org/10.1161/CIRCULATIONAHA.123.067584
- Claudel SE, Verma A — Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review — Circulation, 2025 — doi.org/10.1161/CIRCULATIONAHA.124.071079
Further reading
- Read the broader explanation of the protein being measured in our urine albumin test guide.
- Compare the blood-based version of this screening marker using our microalbuminuria results guide.
- Check the ratio that underpins the categories in our albumin creatinine ratio results guide.
- Explore the filtration marker unaffected by muscle mass through our cystatin C blood level guide.
- Interpret the routine dipstick reading that precedes this test with our urine protein test guide.
Understand your lab results with BloodSense
Get your results interpreted in minutes
A microalbumin result is a screening signal, and its meaning depends on what surrounds it: your filtration rate, blood sugar, blood pressure and the trend across previous tests. BloodSense reads those values together and explains in plain language what the pattern suggests and which questions to raise with your clinician. It helps you understand your results; it does not diagnose kidney disease and it does not replace medical care.
